<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04513821</url>
  </required_header>
  <id_info>
    <org_study_id>CITI-100 EA</org_study_id>
    <nct_id>NCT04513821</nct_id>
  </id_info>
  <brief_title>Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI</brief_title>
  <acronym>MLK</acronym>
  <official_title>CITI-100 EA - Intermediate-Size Expanded Access, Open-Label Study for Use of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of Central Line Associated Bloodstream Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leonard-Meron Biosciences, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Leonard-Meron Biosciences, Inc.</source>
  <brief_summary>
    <textblock>
      This is an Intermediate-Size Expanded Access, Open-Label Study for Use of Mino-Lok Therapy&#xD;
      (MLT) in Combination with Systemic Antibiotics in the Treatment of Central Line Associated&#xD;
      Bloodstream Infection. Mino-Lok may be made available for patients who otherwise do not&#xD;
      qualify for the phase 3 clinical trial (NCT02901717 )&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an Intermediate-Size Expanded Access, Open-Label Study for Use of Mino-Lok Therapy&#xD;
      (MLT) in Combination with Systemic Antibiotics in the Treatment of Central Line Associated&#xD;
      Bloodstream Infection.&#xD;
&#xD;
      Mino-Lok Therapy is being developed as an adjunctive therapy for the treatment of&#xD;
      catheter-related or central line associated bloodstream infection (CRBSI/CLABSI) in&#xD;
      combination with appropriate systemic antibiotic(s), to preserve central venous access and to&#xD;
      avoid the complications and morbidities associated with catheter removal and reinsertion.&#xD;
&#xD;
      This is an expanded access program (EAP). This program is designed to provide access to&#xD;
      Mino-Lok. A physician must decide whether the potential benefit outweighs the risk of&#xD;
      receiving an investigational therapy.&#xD;
&#xD;
      To learn more about this study, please refer to this study by its ClinicalTrials.gov&#xD;
      identifier (NCT number): NCT02901717&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <expanded_access_info>
    <expanded_access_type_intermediate>Yes</expanded_access_type_intermediate>
  </expanded_access_info>
  <condition>Catheter-Related Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mino-Lok Therapy (MLT)</intervention_name>
    <description>Standard of Care antibiotics appropriate for the infecting organism plus Mino-Lok therapy to disinfect and save the catheter. Mino-Lok is made available through this expanded access protocol to patients who otherwise do not qualify for the phase 3 clinical trial (NCT02901717) Other Name: Standard of care antibiotics + Mino-Lok</description>
    <other_name>Standard of care plus MLT. MLT contains minocycline with EDTA and ethanol.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject or a legally authorized representative must provide a signed informed consent&#xD;
             form;&#xD;
&#xD;
          2. The subject should be male or female at least 12 years of age. This product has not&#xD;
             been studied in a younger pediatric population;&#xD;
&#xD;
          3. Subject should have a bloodstream infection with no other apparent source other than&#xD;
             the CVC that meets one of the following criteria:&#xD;
&#xD;
               -  A recognized single pathogen cultured from 1 or more blood cultures; OR&#xD;
&#xD;
               -  A common skin contaminant cultured from 2 or more blood cultures drawn on the&#xD;
                  same or consecutive calendar days from a subject with fever (&gt;38.0 C), chills, or&#xD;
                  hypotension (systolic blood pressure &lt;90 mmHg); Note that these criteria are&#xD;
                  based on the CDCs definition of CLABSI. Please consult the CDC website for&#xD;
                  guidance at https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf.&#xD;
&#xD;
          4. Subjects for whom, in the Investigator's opinion, catheter retention is reasonable or&#xD;
             required;&#xD;
&#xD;
          5. This product has not been studied in women who are pregnant or lactating. It's effect&#xD;
             on sperm development has also not been studied. Please consider this with female&#xD;
             patients that are pregnant or who plan to become pregnant, or female patients who are&#xD;
             breastfeeding. Likewise, male patients should refrain from sperm donation for 90 days&#xD;
             following exposure to MLT. NOTE: Highly effective methods of contraception include&#xD;
             hormonal contraceptives, intrauterine device, double-barrier method, partner&#xD;
             sterility, or abstinence are strongly recommended.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Subjects who meet any of the following criteria should not be exposed to MLT:&#xD;
&#xD;
          1. Subjects with hypersensitivity or allergy to tetracycline antibiotics or edetate&#xD;
             disodium;&#xD;
&#xD;
          2. Subjects taking disulfiram at the time of enrollment or who are expected to take&#xD;
             disulfiram at any time during treatment with study drug;&#xD;
&#xD;
          3. The benefit of MLT in subjects with prosthetic cardiac valves, vascular grafts,&#xD;
             pacers, automatic implantable cardioverter-defibrillator, or other non-removable&#xD;
             vascular foreign body should be evaluated prior to exposure. The Investigator should&#xD;
             be confident that these are not the source of infection;&#xD;
&#xD;
          4. The benefit of MLT in subjects with a deep-seated intravascular source of infection&#xD;
             (eg, endocarditis [as evidenced by vegetations on an echocardiogram or clinical&#xD;
             suspicion] or septic thrombosis) should be evaluated prior to exposure. The&#xD;
             Investigator should be confident that these are not the source of infection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Alan Lader, Ph.D</last_name>
    <phone>908-967-6677</phone>
    <email>expandedaccess@citiuspharma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Phoenix VA Health Care System</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>University of Florida - Shands Hospital - Dialysis Center</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Edward Hines Jr. VA Hospital</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>AMG Oncology</name>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Lutheran Hospital</name>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Indiana Blood and Marrow Institute</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Ascension Via Christi Hospital</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Medical Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Anne Arundel Medical Center</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Harper University Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health Systems</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48083</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>VA Sierra Nevada Health Care Systems</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Saint Michael's Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>East Carolina University</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27858</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>University of Texas MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Salem VA Medical Center</name>
      <address>
        <city>Salem</city>
        <state>Virginia</state>
        <zip>24153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Manati Medical Center</name>
      <address>
        <city>Manat√≠</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>Ponce Research Institute</name>
      <address>
        <city>Ponce</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location>
    <facility>
      <name>VA Caribbean Healthcare System</name>
      <address>
        <city>San Juan</city>
        <zip>00921</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 10, 2020</study_first_submitted>
  <study_first_submitted_qc>August 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2020</study_first_posted>
  <last_update_submitted>August 13, 2020</last_update_submitted>
  <last_update_submitted_qc>August 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Catheter-Related Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Minocycline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

